Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem(R)) for bioequivalence in a randomized, open-label, two-period study
Tags:
Reference:
Malaria Journal 2013, 12:312 (8 September 2013)
These novel formulations are easy to administer and may improve adherence in the treatment of uncomplicated malaria caused by Plasmodium falciparum.
Medical Condition:
